How many studies have been conducted on Nimustine?

BiohacksAI has indexed 300 PubMed studies on Nimustine, including 9 randomized controlled trials (RCTs). 44% of studies involve human subjects.

What are the main research areas for Nimustine?

The primary research domains for Nimustine are 🔬 Oncology, 🫁 Liver & Detox, ⏳ Longevity & Aging. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Nimustine

The resistance which brain tumor cells acquire to the initial effectiveness of this drug can be partially overcome by the simultaneous use of membrane-modifying agents such as reserpine, calcium antagonists such as nicardipine or verapamil, or the calmodulin inhibitor, trifluoperazine. The drug has also been used in combination with other antineoplastic agents or with radiotherapy for the treatment of various neoplasms.

300+ PubMed studies analyzed · 9 RCTs · Evidence Score: 46.1

Research Domains

Nimustine has been studied across 14 research domains including 🔬 Oncology, 🫁 Liver & Detox, ⏳ Longevity & Aging, 🛡️ Immunity, ✨ Skin & Hair. The primary research focus is 🔬 Oncology with 80% of studies addressing this area.

Loading evidence profile...

This evidence profile for Nimustine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.